582 related articles for article (PubMed ID: 8500238)
1. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
2. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
3. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
Johnson G; Carson P; Francis GS; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
[TBL] [Abstract][Full Text] [Related]
4. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
Cohn JN; Johnson GR; Shabetai R; Loeb H; Tristani F; Rector T; Smith R; Fletcher R
Circulation; 1993 Jun; 87(6 Suppl):VI5-16. PubMed ID: 8500240
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Cintron G; Johnson G; Francis G; Cobb F; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI17-23. PubMed ID: 8500235
[TBL] [Abstract][Full Text] [Related]
6. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
Fletcher RD; Cintron GB; Johnson G; Orndorff J; Carson P; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI49-55. PubMed ID: 8500239
[TBL] [Abstract][Full Text] [Related]
7. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
[TBL] [Abstract][Full Text] [Related]
8. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Carson PE; Johnson GR; Dunkman WB; Fletcher RD; Farrell L; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI102-10. PubMed ID: 8500233
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
Goldman S; Johnson G; Cohn JN; Cintron G; Smith R; Francis G
Circulation; 1993 Jun; 87(6 Suppl):VI24-31. PubMed ID: 8500236
[TBL] [Abstract][Full Text] [Related]
10. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Rector TS; Johnson G; Dunkman WB; Daniels G; Farrell L; Henrick A; Smith B; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI71-7. PubMed ID: 8500243
[TBL] [Abstract][Full Text] [Related]
11. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Dunkman WB; Johnson GR; Carson PE; Bhat G; Farrell L; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI94-101. PubMed ID: 8500246
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group.
Hughes CV; Wong M; Johnson G; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI111-7. PubMed ID: 8500234
[TBL] [Abstract][Full Text] [Related]
13. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
14. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
Carson P; Johnson G; Fletcher R; Cohn J
J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
[TBL] [Abstract][Full Text] [Related]
15. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
[TBL] [Abstract][Full Text] [Related]
16. Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.
Cohn JN
Drugs; 1994; 47 Suppl 4():47-57; discussion 57-8. PubMed ID: 7523062
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group.
Wong M; Johnson G; Shabetai R; Hughes V; Bhat G; Lopez B; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI65-70. PubMed ID: 8500242
[TBL] [Abstract][Full Text] [Related]
18. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
[TBL] [Abstract][Full Text] [Related]
19. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
Cohn JN
Herz; 1991 Sep; 16 Spec No 1():267-71. PubMed ID: 1820292
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
Carson P; Ziesche S; Johnson G; Cohn JN
J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
